Eton Pharmaceuticals (ETON) Other Working Capital Changes (2018 - 2025)

Eton Pharmaceuticals has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $2.5 million for Q4 2025.

• Other Working Capital Changes for Q4 2025 came in at $2.5 million, down 28.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.0 million (down 41.15% YoY), and the FY2025 annual result was $2.0 million, down 41.15% from the prior year.
• Other Working Capital Changes came in at $2.5 million for Q4 2025 at Eton Pharmaceuticals, up from $122000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $3.5 million in Q4 2024 to a low of -$3.0 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is $21500.0 (2024), against an average of $220600.0.
• Across the five-year window, Other Working Capital Changes surged 1400.0% in 2021 and sank 3663.29% in 2025, its largest moves.
• Eton Pharmaceuticals' Other Working Capital Changes stood at $743000.0 in 2021, then plunged by 61.1% to $289000.0 in 2022, then soared by 126.64% to $655000.0 in 2023, then surged by 437.4% to $3.5 million in 2024, then dropped by 28.38% to $2.5 million in 2025.
• The last three Other Working Capital Changes figures came in at $2.5 million (Q4 2025), $122000.0 (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.